ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LNTH vs JNJ // 10Y YIELD & FRED MACRO BETA

Lantheus Holdings Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: LNTH 2 — JNJ 11
▲ 10Y YIELD & FRED MACRO BETA LEADER: JNJ
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LNTH JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 61.10% 67.90% -6.80 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 20.30% 25.50% -5.20 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 18.0x 18.5x -0.50 LNTH /valuation <GO>
Free Cash Flow Yield 4.90% 2.97% +1.93 LNTH /fcf-yield <GO>
Operating Margin 20.20% 34.70% -14.50 JNJ /operating-margins <GO>
Net Profit Margin 15.20% 28.50% -13.30 JNJ /net-margins <GO>
Revenue Growth (YoY) 0.50% 6.00% -5.50 JNJ /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.34 5.59 -0.25 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.1 62.1 -9.00 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE 0.88 1.08 -0.20 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 26.0x 23.0x +3.00 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $6.55B $662.49B -$655.94B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LNTH REV JNJ REV LNTH GROSS % JNJ GROSS % LNTH FCF JNJ FCF
FY 2025 $1.54B $94.19B 61.1% 67.9% $320.8M $19.70B
FY 2024 $1.53B $88.82B 64.4% 69.1% $475.7M $19.84B
FY 2023 $1.30B $85.16B — — $246.9M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
JNJ // BETA 1.08